HBMHF — Stock activity · TradeandTellHBMH
HBMHF
$1.56-$0.96 (-38.10%)prev close
Held by
0
portfolios on TandT
Avg position size
—
of holders' portfolios
52-week range
$1.56 – $2.54
0% from low
Held by traders on TradeandTell
No one on the platform currently holds HBMHF.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in HBMHF as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded HBMHF yet.
Insider activity (SEC Form 4)
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Analyst estimates (consensus)
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|
| 2026 | $235M | +24.7% | $0.13 | $0.12–$0.14 | 11.9× | 1 |
| 2027 | $221M | -5.8% | $0.12 | $0.12–$0.13 | 12.7× | 1 |
| 2028 | $255M | +15.2% | $0.14 | $0.13–$0.15 | 11.2× | 1 |
| 2029 | $200M | -21.4% | $0.00 | $0.00–$0.00 | — | 0 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Peer comparison
| Symbol | Price | Today | Mkt cap | P/E |
|---|
| HBMHFHBM Holdings Limited | $1.56 | +0.00% | $1.3B | — |
| ABOSAcumen Pharmaceuticals, Inc. | $2.68 | +5.14% | $194M | — |
| ACXPAcurx Pharmaceuticals, Inc. | $1.39 | -6.07% | $6M | — |
| ANEBAnebulo Pharmaceuticals, Inc. | $0.40 | +31.67% | $16M | — |
| BPTHBio-Path Holdings, Inc. | $0.04 | +16.00% | $379291 | — |
| CINGCingulate Inc. | $5.00 | +0.10% | $67M | — |
Source: Financial Modeling Prep · peers by sector/industry
| DAWNDay One Biopharmaceuticals, Inc. | $21.53 | +0.00% | $2.2B | — |